Medical Industry Today
SEE OTHER BRANDS

Bringing you the latest news on healthcare and wellness

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Medical Industry Today.

HealthLink Dimensions Debuts New Brand Experience to Match Growing Capabilities

HealthLink Dimensions Debuts New Brand Experience to Match Growing Capabilities

ATLANTA, GA, UNITED STATES, June 24, 2025 /⁨EINPresswire.com⁩/ -- With rapid expansion across its data assets, solution portfolio, and client base, HealthLink Dimensions has significantly grown its role in solving complex challenges for the...

Regeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance Organization

Regeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance Organization

TARRYTOWN, N.Y., June 24, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the launch of a pioneering matching program for donations to Good Days, an independent national non-profit charitable organization,...

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics

Vancouver, Canada, June 24, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived...

New AHA TV, digital ad urges Congress to protect access to hospital care 

New AHA TV, digital ad urges Congress to protect access to hospital care 

The AHA this week is launching a new ad urging Congress to protect access to hospital care as it considers legislation that could have far-ranging negative consequences for patients, communities and hospitals across America. The ad highlights how,...

HHS announces initiative with insurers to streamline prior authorizations 

HHS announces initiative with insurers to streamline prior authorizations 

The Department of Health and Human Services June 23 announced an initiative coordinated with multiple health insurance companies to streamline prior authorization processes for patients covered by Medicare Advantage, Medicaid managed care plans,...

AHA podcast: 20% Drop in Sepsis Mortality — Inside Ochsner Health’s Life-Saving Strategy 

AHA podcast: 20% Drop in Sepsis Mortality — Inside Ochsner Health’s Life-Saving Strategy 

Wrenetha Julion, Ph.D., R.N., of Rush University Medical Center, and Paul Florsheim, Ph.D., of the University of Wisconsin-Milwaukee, discuss the collaborative…

FDA grants accelerated approval to datopotamab deruxtecan-dlnk for EGFR-mutated non-small cell lung cancer

FDA grants accelerated approval to datopotamab deruxtecan-dlnk for EGFR-mutated non-small cell lung cancer

On June 23, 2025, the Food and Drug Administration granted accelerated approval to datopotamab deruxtecan-dlnk (Datroway, Daiichi Sankyo, Inc.) for adults with locally advanced or metastatic epidermal growth factor receptor (EGFR)-mutated...

Dr Arash Fattahi wins 2025 RCP Teale essay prize

Dr Arash Fattahi wins 2025 RCP Teale essay prize

The Royal College of Physicians (RCP) has announced Dr Arash Fattahi as the winner of the 2025 Teale Essay Prize for his essay on whether we should end rotational training for physicians. Dr Fattahi’s essay examines the history of rotational...

Q1 Stability Testing of Drug Substances and Drug Products

Q1 Stability Testing of Drug Substances and Drug Products

Docket Number: FDA-2025-D-1106 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research Center for Biologics Evaluation and Research The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft...

Fibrillating Rollers Market to Reach USD 5.3 Billion by 2033, Driven by Food & Medical Industry Demand

Fibrillating Rollers Market to Reach USD 5.3 Billion by 2033, Driven by Food & Medical Industry Demand

Fibrillating rollers enhance paper & films for high-performance use, with growing demand in medical and eco-friendly applications due to their unique properties NEWARK, DE, UNITED STATES, May 26, 2025 /⁨EINPresswire.com⁩/ -- The global...

Questex’s Fierce Pharma Unveils Powerhouse Conference Program for the Inaugural Fierce Pharma Week, Where Pharma’s Future Takes Shape

Questex’s Fierce Pharma Unveils Powerhouse Conference Program for the Inaugural Fierce Pharma Week, Where Pharma’s Future Takes Shape

Unites Pharma Marketing, PR & Communications, New Product Planning & Commercialization, and Medical Affairs Communities; Thought Leaders from AbbVie, AstraZeneca, BMS, GSK, Johnson & Johnson, NBCUniversal, Pfizer, Takeda and More Deliver...

Cancer Immunotherapy Surging with Checkpoint Inhibitors & CAR-T, Market to Reach $261B by 2033 | DataM Intelligence

Cancer Immunotherapy Surging with Checkpoint Inhibitors & CAR-T, Market to Reach $261B by 2033 | DataM Intelligence

Cancer Immunotherapy Market booming with innovative therapies, projected to hit $261.74B by 2033, reshaping oncology worldwide. AUSTIN, TX, UNITED STATES, June 23, 2025 /⁨EINPresswire.com⁩/ -- Cancer Immunotherapy Market reached US$ 137.70 billion...

Candel Therapeutics Appoints Charles Schoch as Chief Financial Officer

Candel Therapeutics Appoints Charles Schoch as Chief Financial Officer

NEEDHAM, Mass., June 23, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight...

ORYZON Announces Submission of Phase III Protocol to FDA to Initiate PORTICO-2 Trial of Vafidemstat in Borderline Personality Disorder (BPD) Patients

ORYZON Announces Submission of Phase III Protocol to FDA to Initiate PORTICO-2 Trial of Vafidemstat in Borderline Personality Disorder (BPD) Patients

PORTICO-2 designed to validate vafidemstat’s efficacy in reducing aggression in BPD patients Primary endpoint: STAXI-2 Trait Anger (patient-reported) Key secondary endpoint: Overt Aggression Scale-Modified (OAS-M) (clinician-rated) Additional...

Bestselling Book 'Your Brain Is a Filthy Liar' Exposes Self-Deception & Why Mental Health Won’t Address

Bestselling Book 'Your Brain Is a Filthy Liar' Exposes Self-Deception & Why Mental Health Won’t Address

SANDPOINT, ID, UNITED STATES, June 23, 2025 /⁨EINPresswire.com⁩/ -- Your Brain Is a Filthy Liar, the latest release from author and mental health innovator Bizzie Gold, reached bestseller status on Amazon.com two days after its global launch. This...

RAPT Therapeutics Names Two Industry Veterans to its Board of Directors

RAPT Therapeutics Names Two Industry Veterans to its Board of Directors

SOUTH SAN FRANCISCO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients...

NetraMark's AI Significantly Outperforms ChatGPT, DeepSeek and Traditional Machine Learning in Clinical Trial Subpopulation Discovery, Offers New Path for Trial Success

NetraMark's AI Significantly Outperforms ChatGPT, DeepSeek and Traditional Machine Learning in Clinical Trial Subpopulation Discovery, Offers New Path for Trial Success

TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials has released a new...

Purple Biotech Highlights Significant Advantages of the Novel CAPTN-3 Tri-Specific Antibody Platform at the EACR 2025 Annual Congress

Purple Biotech Highlights Significant Advantages of the Novel CAPTN-3 Tri-Specific Antibody Platform at the EACR 2025 Annual Congress

REHOVOT, Israel, June 23, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug...

CoachCare Acquires MD Revolution, Creating the Nation’s Leading Remote Care Platform

CoachCare Acquires MD Revolution, Creating the Nation’s Leading Remote Care Platform

Combined company will lead the future of remote care across fee-for-service and value-based models with unparalleled technology, services, and scale. NEW YORK, NY, UNITED STATES, June 23, 2025 /⁨EINPresswire.com⁩/ -- CoachCare, a leading remote...

YURiNOX Launches 4-Way Stretch Fabric for High Motion Range in Workwear

YURiNOX Launches 4-Way Stretch Fabric for High Motion Range in Workwear

YURiNOX unveils Ergofive Active—4-way stretch workwear designed for durability, comfort, and mobility in high-motion professions. BROOKLYN, NY, UNITED STATES, June 23, 2025 /⁨EINPresswire.com⁩/ -- Trusted professional apparel and uniform brand,...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service